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EpidermisConnexin (Cx) proteins form intercellular gap junction channels by ﬁrst assembling into single membrane
hemichannels that then dock to connect the cytoplasm of two adjacent cells. Gap junctions are highly special-
ized structures that allow the direct passage of small molecules between cells to maintain tissue homeostasis.
Functional activity of nonjunctional hemichannels has now been shown in several experimental systems.
Hemichannels may constitute an important diffusional exchange pathway with the extracellular space, but
the extent of their normal physiological role is currently unknown. Aberrant hemichannel activity has been
linked to mutations of connexin proteins involved in genetic diseases. Here, we review a proposed role for
hemichannels in the pathogenesis of Keratitis–Ichthyosis–Deafness (KID) syndrome associated with con-
nexin26 (Cx26) mutations. Continued functional evaluation of mutated hemichannels linked to human he-
reditary disorders may provide additional insights into the mechanisms governing their regulation in
normal physiology and dysregulation in disease. This article is part of a Special Issue entitled: The Communi-
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Intercellular communication is a hallmark of multicellular organ-
isms. In chordate animals, the connexin family of structural proteins
forms intercellular membrane channels called gap junctions [1]. Con-
nexin (Cx) proteins have been studied for nearly ﬁve decades in thecontext of these intercellular gap junction channels that facilitate
electrical and biochemical coupling of adjacent vertebrate cells
[2–5]. Gap junctions are well characterized with regard to their role
in maintaining tissue homeostasis by enabling exchange of ions, sec-
ond messengers, and metabolites [6–9]. Connexins are now known
to also be capable of forming functional hemichannels in nonjunc-
tional membranes, linking the cytoplasm of a cell with its extra-
cellular microenvironment [10–14]. Hemichannels are thought to
participate in paracrine functions and there is evidence to indicate
that hemichannels mediate calcium signaling through ATP release
[15,16]. Hemichannels presently have an unclear role in normal phys-
iology, but there is accumulating evidence showing that their activity
can be altered under certain pathological conditions [17].
Mutations of connexin-encoding genes contribute to the etiology
of a variety of human genetic diseases, including, but not limited to,
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syndromic sensorineural deafness [5,18–21]. New mutations are con-
tinually discovered due to improved availability and affordability of
DNA sequencing technology at academic medical centers and the
high frequency of mutations in some human connexins, like con-
nexin26 (Cx26). These ﬁndings establish a genetic basis for clinical ill-
ness, but provide little insight regarding pathophysiological
mechanistic details. Connexin proteins are key players in a diverse
set of fundamental cellular processes, leaving numerous possible tar-
gets for pathological interference that may include hemichannels.
Filling in the gaps between connexin mutations and phenotypic con-
sequences will help inform efforts to develop targeted therapies.
Here, we focus on pathological hemichannel activation that may
lead to disturbances in the normal patterns of keratinocyte prolif-
eration and differentiation in the skin and have been implicated as a
gap junction-independent mechanism of disease in the context of
Keratitis–Ichthyosis–Deafness (KID) syndrome. The most frequently
mutated connexin in the epidermis, Cx26, will be used as a model
for discussion.
2. Connexin hemichannels
Connexins are 4-transmembrane domain proteins that oligomer-
ize to form hexameric structures that have been termed connexons
or hemichannels [10]. Gap junctions are assembled when hemichan-
nels in the membranes of two adjacent cells become aligned at their
extracellular surfaces [2]. Hemichannels may be assembled from 6 of
the same connexin to form so-called homomeric structures, or may
be constituted by a combination of different connexins, producing
heteromers. The connexin composition of hemichannels is depen-
dent on cell-type and may affect channel properties, including per-
meability to second messengers and other solutes [20,22].
Evidence for active hemichannels was ﬁrst observed in vivo by
whole-cell voltage clamp studies of solitary horizontal cells isolated
from the catﬁsh and skate retina [23,24]. A time- and voltage-dependent
outwardly rectifying membrane current was identiﬁed with behaviors
consistent with half of a gap junction channel [23]. The existence of
active hemichannels was initially suggested by in vitro expression of
cloned connexins in single Xenopus oocytes, which resulted in in-
creased membrane currents and permeability to ﬂuorescent probes
[25]. Single-channel conductances have now been shown by various
mammalian cell-expression systems to substantiate these ﬁndings
[26–28].
Hemichannels are thought to rest in a predominantly closed state
in vivo, with transient openings in response to a wide range of stimuli
[12]. Interestingly, hemichannel conductance is modulated by trans-
membrane voltage, calcium concentration, and intracellular pH as
well as other variables known to regulate gap junction permeability
[29–31]. Post-translational covalent modiﬁcations of connexin carboxy-
terminal amino acids may also inﬂuence hemichannel open proba-
bility [32–35]. Finally, increased activity of hemichannels may also
result from pathological mutations in connexin proteins. Although
insights have been gained into the mechanisms of hemichannel gating,
the impact of hemichannel activity on tissue homeostasis remains poor-
ly understood at this time, making it difﬁcult to evaluate possible phys-
iological roles for normal hemichannel activity.
Disease-causing connexinmutations are largely single amino acid
deletions or substitutions that have the potential to modify the topo-
logical and biochemical characteristics of the proteins and subse-
quently impact the function of the channels they form. Preliminary
experimental work has suggested that mutations in connexin genes
can functionally alter hemichannel properties with potentially dele-
terious consequences for the cell [36–40]. Constitutively active, or
dysregulated ‘leaky’ hemichannels may deplete the cytoplasm of essen-
tial small molecules, depolarize the plasma membrane by permitting
uncontrolled uptake of molecules, or cause lysis via osmotic pressures[40]. To date, there have been no conclusive ﬁndings showing aberrant
hemichannel ﬂuxes as causative of clinical phenotypes.
3. Connexin26 in epidermal pathology
At least 9 of the known 21 human connexin isoforms are found in
skin. Connexins have overlapping expression patterns in the three
inner layers of the epidermis and are thought to mediate the contin-
uous process of keratinocyte renewal [20,41,42]. Dye-transfer studies
have conﬁrmed the presence of gap junctional communication in
human and mouse skin [43,44]. Connexin proteins have dynamic
spatial and temporal expression patterns and are most notably upre-
gulated in states of increased keratinocyte proliferation and differentia-
tion. For example, Cx26 is highly overexpressed in hyperproliferative
psoriatic plaques [45,46] as well as neoplastic papilloma lesions [47].
Experimentally induced wounds result in differential changes in con-
nexin expression: upregulation in the wound proper and downregula-
tion at the wound periphery [48,49]. Finally, in patients with skin
disorders linked to Cx26 mutations, expression of the mutant protein
is greatly increased in the diseased epidermis [50]. At face value, these
observations could be taken to imply an important role for Cx26 pro-
teins in keratinocyte regulation.
Cx26 is found in keratinocytes of the stratum basale and stratum
granulosum as well as other organ systems [42,44,48,51]. Mutations
in GJB2, the gene encoding Cx26, are linked to congenital sensori-
neural deafness as well as syndromic hearing loss associated with
skin disorders [52]. Cx26 mutations are known to be the leading
cause of autosomal recessive hearing loss, predominantly through a
loss-of-function mechanism. The most common Cx26 mutation lead-
ing to non-syndromic deafness in Caucasian families is the single
nucleotide deletion 35delG [53], which produces a frameshift that
truncates the protein after encoding only a short segment of the
amino-terminus, rendering it entirely non-functional. Similarly, the
most prevalent Cx26 mutations leading to deafness in eastern Asian
populations and Ashkenazi Jewish populations are 235delC and
167delT respectively, both of which also cause premature termina-
tion of the protein [54,55]. Testing of other mutations has shown
that loss of channel function ranges from partial-to-complete and
may result from impaired trafﬁcking of proteins to the plasma mem-
brane and improper open-channel assembly. It is important to note
that inherited deafness is genetically diverse and, though less com-
mon, cases are also linked to mutations in Cx26 that yield channels
retaining some level of function. However, such mutations commonly
produce channels with distinctly altered gating and permeability
properties; it is often the case that they become impermeable to mol-
ecules regularly passed by wild-type channels [56,57]. For example,
the V84L mutation found in recessive non-syndromic deafness
forms channels with similar gross unitary channel conductance to
wild-type Cx26 gap junctions but with deﬁcient permeability to inosi-
tol 1,4,5-trisphosphate [58,59]. Thus, total or partial loss-of-function
mutations are responsible for non-syndromic deafness and these
patients do not suffer from defective cutaneous wound healing or skin
abnormalities [60,61], other than anecdotal reports of increased epi-
dermal thickness [62,63].
In contrast to the numerous Cx26mutations causing non-syndromic
deafness, those that also cause skin disease are all single amino acid
changes with autosomal dominant inheritance patterns that confer
either some type of pathological gain- or alteration-of-function
[64–66]. These missense mutations are clustered in the amino-
terminus and ﬁrst extracellular loop of the protein and lead to a
broad spectrum of dermatologic presentations [51]. Two main hypoth-
eses follow: 1) Cx26 mutations that cause skin disorders do so by a
novel gain- or alteration-of-function and 2) overexpression of mutated
forms of Cx26 linked to KID syndrome in the epidermis in response to
tissue injury [45–47] may in fact be harmful if active hemichannels
are formed.
Table 1
Biophysical evidence of increased Cx26 hemichannel activity in GJB2mutations causing
KID syndrome via single-cell electrophysiology.
Mutation Oocyte voltage-clamp Mammalian
cell patch-clamp
Refs.
A40V Yes Yes [37,39,76] (Fig. 2)
G45E Yes Yes [36,37,76] (Fig. 2)
D50N Yes ? [38]
N14K Yes ? [38]
G12R Yes ? [38]
S17F No ? [38]
2016 N.A. Levit et al. / Biochimica et Biophysica Acta 1818 (2012) 2014–2019Single-cell voltage clamp experiments in Xenopus oocytes ini-
tially identiﬁed a Cx26 mutant linked to deafness and skin disease
exhibiting aberrant hemichannel activity [39]. Subsequently, hemi-
channel activity was evaluated for additional mutations in syn-
dromic deafness, and has currently been shown to be a common
feature of the G45E, A40V, N14K, D50N, and G12R mutations causing
Keratitis–Ichthyosis–Deafness (KID) syndrome (OMIM 148210)
[36,38,39,67–71] (Table 1). Palmoplantar Keratoderma (PPK) with
Deafness (OMIM 148350) is a clinically distinct Cx26 congenital syn-
drome with no known role for hemichannel activity [50, 72]. The
skin pathology in PPK is thought to proceed from Cx26 mutations
via trans-dominant inhibition of other connexins residing in the
epidermis, such as connexin43 or connexin30 [50,73]. Notably, visu-
alization of a three-dimensional Cx26 hemichannel [74] shows mu-
tations in KID to be spatially oriented near pore-lining residues
while those in PPK are more evenly distributed throughout the chan-
nel wall (Fig. 1), underscoring the potential of the former group to
have direct implications on pore conformation and gating. There
are also rare KIDmutations that are not associated with hemichannel
dysfunction, such as S17F [38]. In addition, several KID mutations
have not yet been tested. It has been hypothesized that those lacking
hemichannel activity may lead to distinct dermatologic phenotypes,
but this has been difﬁcult to conclusively establish due to the small
number of cases and heterogeneous nature of the disorders [75].
4. Connexin26 hemichannel properties
The biophysical properties of hemichannels formed by two KID
mutations, G45E and A40V [39,67,69], have been examined in the
greatest detail. G45E in particular is linked to high patient mortality
within the ﬁrst year of life [67,69,76,77]. Both show uniquely large
hemichannel currents when expressed in single cells, surpassing
any recorded wild-type connexin hemichannel currents that may
contribute to normal homeostatic maintenance [36,37,39]. This
ﬁnding is consistent in data derived from oocyte voltage-clampFig. 1. Three-dimensional structure of a Cx26 hemichannel. Mutated residues linked to Ke
derma with deafness (pink) are mapped onto three of the six subunits of the reported Cx
which consists of 4 transmembrane domains, 2 extracellular loops, and 1 cytoplasmic loo
side of the channel, including both the amino and carboxy-termini. (C) Lateral view of the
of mutations. The yellow residues have been associated with aberrant hemichannel activityexperiments as well as patch-clamp recordings from transfected
mammalian cells (Fig. 2). Furthermore, both mutations lead to
rapid oocyte lysis and death in culture. Membrane depolarization
and decreases in extracellular calcium have been shown to cause
exaggerated activation of mutant hemichannels [36–39]. Converse-
ly, hyperpolarization and high concentrations of divalent cations in
the extracellular milieu stabilize the cell membrane and delay cell
death (Fig. 3) [38,78]. Increased extracellular calcium positively
shifts the activation voltage of hemichannels, leading to tighter gat-
ing and mitigation of excessive hemichannel currents.
A recent study sought to quantify hemichannel regulation by
extracellular calcium for wild-type Cx26 as well as the G45E and
A40Vmutants [79]. Connexins were exogenously expressed in Xenopus
oocytes and macroscopic hemichannel currents were recorded by
two-electrode voltage clamp during sequential perfusion with in-
creasing concentrations of calcium. For wild-type Cx26 hemichannels
held at voltages approximating normal keratinocyte membrane poten-
tials, low extracellular calcium resulted in detectable currents that were
progressively reduced as extracellular calcium was increased. The A40V
mutant hemichannel showed larger currents with a shifted response
curve, suggesting reduced regulation by calcium. In contrast, the G45E
mutation showed increased permeability to calcium, compared to wild-
type Cx26, and follow up experiments with the substituted cysteine ac-
cessibility method (SCAM) demonstrated that G45E is a pore-lining res-
idue, implying a tentative role in channel gating and permeability [79].
Residues 40 and 45 localize to the proximal portion of the Cx26 ﬁrst
extracellular domain, and mutations of either result in severe forms of
KID syndrome [51]. However, the development of aberrant hemichan-
nel currents may proceed via distinct functional alterations of channel
properties related to three-dimensional structure and electrochemical
interactions dictated by the speciﬁc amino acid substitutions. The
speciﬁcity of amino acid substitution is underscored by the apparent
discrepancy in clinical phenotypes for twomutations of the same aspar-
agine residue, N14K and N14Y. Each is associated with KID syndrome,
but the skin pathologies are divergent [71,75]. Moreover, N14K pro-
duces aberrant hemichannel currents whereas N14Y does not [80].
Whether excessive hemichannel currents are sufﬁcient to cause
reduced cell viability and epidermal pathology remains to be deﬁni-
tively shown. Xenopus oocyte expression systems show a consistent
correlation between large single-cell transmembrane currents and
accelerated cell death [37,39]. The cellular lethality of G45E hemichan-
nels was independently validated in transfected HEK-293 cells [36].
Recently, HeLa cell culture following transfection of the hemichannel-
forming N14K Cx26 construct also showed increased cell death [75].
Mammalian cells are cultured in serum-containing media that is rich in
growth factors and signalingmolecules thatmay inﬂuence hemichannel
patency and permeability. Studies suggesting that discrepancies exist inratitis–Ichthyosis–Deafness syndrome (yellow and orange) and Palmoplantar Kerato-
26 crystal structure [60]. The blue protein backbone illustrates the topology of Cx26,
p. (A) View of the extracellular portion of the channel. (B) View of the cytoplasmic
channel with 3-subunits and the protein backbone removed to simplify visualization
when mutated and are spatially conﬁned to pore-lining domains.
Fig. 2. Membrane current recordings in Xenopus oocytes (A–C) and N2A cells expressing wild-type connexin26 (A, D) as well as Cx26-A40V (B, E) and Cx26-G45E (C, F). Oocyte
expression assay is accomplished by microinjection of cloned human Cx26 mRNA. Single-cell voltage clamp (A–C) is performed with a holding potential of −40 mV and voltages
ranging from −30 mV to +60 mV are tested with 5-second pulses. Mammalian cell expression system involves transfection with plasmid vectors containing the human Cx26
coding region. Whole-cell patch-clamp data corresponds to voltages ranging from −90 mV to +90 mV. Cx26-G45E and Cx26-A40V show elevated hemichannel currents relative
to wild-type in both Xenopus oocytes and N2A cells.
Fig. 3. The G45E Cx26 mutant leads to accelerated cell death when expressed in Xenopus oocytes which can be rescued by culture in elevated Ca++. H2O-injected (left), wild-
type Cx26-injected (middle), and G45E Cx26-injected (right) cells were incubated in 0 mM (A–C) or 4 mM extracellular Ca++ (D–F) for 40 h. Cells expressing the G45E Cx26
mutant exhibit pigment disorganization, blebbing, and/or lysis in the low calcium condition but resembled the healthy negative and positive control cells in the high calcium
condition.
2017N.A. Levit et al. / Biochimica et Biophysica Acta 1818 (2012) 2014–2019
2018 N.A. Levit et al. / Biochimica et Biophysica Acta 1818 (2012) 2014–2019data derived from oocyte assays and data obtained from transfected
mammalian cells should be cautious about drawing conclusions from
subjective dye permeation assays [75], as themore quantitative biophys-
icalmethods of evaluating hemichannel activity throughdirectmeasure-
ment ofmembrane current have been in good agreement (Fig. 2). Still, in
vivoworkwith transgenic animals is needed to followuphypotheses de-
veloped from in vitro ﬁndings to conclusively deﬁne a role for hemichan-
nel-mediated pathology in differentiating keratinocytes.
The experimental use of pharmacological channel inhibitors may
help elucidate the degree to which gained hemichannel function con-
tributes to disease pathogenesis. The search for connexin-efﬁcacious
blockers among chemical agents known to function on other proteins
involved in membrane transport has produced candidate blocker
molecules such as 2-aminoethoxydiphenyl borate (2-APB), 5-nitro-
2-(3-phenylpropylamino)-benzoate (NPPB), or ﬂufenamic acid (FFA)
[81–85]. As is the case with extracellular divalent cations (Ca++,
Zn++, Mg++) [30], hemichannels formed from different mutant sub-
units may show differing sensitivities to drugs. FFA achieves rapid
and reversible suppression of hemichannel currents in wild-type
Cx26 as well as mutants (Fig. 4). FFA was previously shown to effec-
tively repress the propagation of calcium waves and ATP release
through connexin hemichannels in astrocytes [16]. It is important
to note that the mechanisms of blockade are not well deﬁned and
may be indirect, with ancillary effects on unknown targets. Identify-
ing or developing small molecule inhibitors of higher speciﬁcity
and potency is limited by the requirement for testing of connexin
mutants individually. However, this may be a worthwhile avenue
to explore given the topical accessibility of connexin-expressing ker-
atinocytes in the epidermis.
Further support for a generalizable role of aberrant hemichannels
in epidermal pathology can be drawn from studies of mutations in
GJB6, the gene that encodes Cx30. Mutations in Cx30 are linked to
hidrotic ectodermal dysplasia (HED). Two mutant proteins, G11R and
A88V, were reported to cause cell death when expressed in Xenopus
oocytes by microinjection of the connexin mRNA [40]. Additionally,
large voltage-activated currents were detected in mutant cells that
were absent in wild-type controls. Transfection of HeLa cells with the
Cx30 mutants resulted in increased ATP leakage into the extracellular
medium [40]. Excessive release of metabolites may not only be injuri-
ous to individual cells, but could also constitute a paracrine message
to propagate untoward effects throughout the tissue.Fig. 4. Hemichannel current suppression by ﬂufenamic acid. A single G45E Cx26-
expressing oocyte was held at −40 mV and pulsed successively at 100 mV for 10 min.
Bars correspond to the average membrane current recorded during each voltage
pulse. 2 min was allowed for membrane stabilization before perfusion with 150 μM
FFA for 3 min. Hemichannel currents shown are normalized to the initial value to
monitor fractional change. N80% hemichannel current inhibition is achieved with
150 μM FFA that is partially reversed by 5 min of washout with the drug-free
culture medium.In summary, skin disease-associated mutations of connexin pro-
teins can cause functional disturbances in hemichannel activity that
may, or may not, be accompanied by changes in gap junctional inter-
cellular conductance. It is likely that multiple disease mechanisms,
including alteration of hemichannel activity, are involved across the
wide spectrum of hereditary diseases involving connexin proteins.
Indeed, mechanisms may even vary within individual clinical classiﬁ-
cations, but further characterization is necessary. Experimental para-
digms combining speciﬁc small molecule inhibitors with animal
models will be a powerful next step toward conﬁrming, or eliminat-
ing, the proposed role of hemichannel openings in skin disease. As
an additional beneﬁt, novel therapeutic strategies to rescue tissue
integrity may emerge in the process.
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